Current or prior use of immunosuppressive medication within  days prior to the first dose Additional Exclusion Criteria for Arm A
Use of immunosuppressive medication at the time of enrollment
Participant must not have current or prior use of immunosuppressive medication within  days prior to the first dose (with certain exceptions).
Current or prior use of immunosuppressive medication within  days prior to the first dose (with certain exceptions).
Current or prior use of immunosuppressive medication within  days before the first study treatment
Current or prior use of immunosuppressive medication within  days prior to study entry
Current or prior use of immunosuppressive medication within  days with some exceptions
Current or prior use of immunosuppressive medication within  days prior to the first dose of study treatment
Current or prior use of immunosuppressive medication within  days prior to the first dose (with certain exceptions).
Prior use of levothyroxine
Prior use of gossypol or AT-
Current or prior use of immunosuppressive medication within  days prior to the first dose of MEDI
Current use of immunosuppressive medication at study entry, with the following exceptions:
Current use of immunosuppressive medication at the time of study enrollment.
Current use of more than one antihypertensive medication.
Current or prior use of immunosuppressive medication within  days with some exceptions.
Concurrent or prior use of immunosuppressive medication with  days
Subject use of immunosuppressive medication within  days before Cycle  Day .
Current or prior use of immunosuppressive medication within  days prior to the first dose of study treatment. The following are exceptions to this criterion:
Current or prior use of immunosuppressive medication within  days before the first dose of study drugs
Current or prior use of immunosuppressive medication within  days prior to the first dose of IP. The following are exceptions to this criterion:
Current or prior use of immunosuppressive medication within  days before start of treatment.
Current or prior use of immunosuppressive medication within  days of first dose
Current or prior use of immunosuppressive medication within  days before the first dose of their assigned Investigational Product;
Current or prior use of immunosuppressive medication within  days prior to the first dose of MEDI. )
Current or prior use of immunosuppressive medication within  days before the first dose of MEDI
Current use of immunosuppressive medication at the time of study enrollment.
Ongoing ? Grade  toxicities from previous cancer therapies unless specifically allowed in the Inclusion/Exclusion criteria. Use of immunosuppressive medication other than steroids within  days before the first dose of MEDI-
Current use of systemic steroid medication
Concurrent or prior use of immunosuppressive medication within  days;
Concurrent or prior use of immunosuppressive medication within  days
Use of immunosuppressive medication or systemic steroids within  days prior to first dose of MEDI
Current or prior use of immunosuppressive medication within  days prior to the first dose of study treatment
Current use of cytotoxic or immunosuppressive drugs
Prior or current use of statin medication
